Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| intestinal obstruction | DOID_8437 | |
| myocardial stunning | DOID_9767 | |
| HYPER flask | BAO_0002520 | |
| tissue culture flask | BAO_0002192 | |
| triple flask | BAO_0002521 | |
| H69AR cell | CLO_0003610 | |
| computational profile endpoint | BAO_0002137 | |
| gene-expression profile endpoint | BAO_0002138 | |
| hyaluronic acid synthesis inhibitor | CHEBI_131561 | |
| beta-arrestin clustering assay | BAO_0080034 | [The Transfluor assay employs a a beta-arrestin-GFP fusion protein to detect activation of GPCRs: Upon ligand binding the GPCR, cytosolic arrestin-GFP quickly translocates to the cell membrane and then to endocytic vesicles, where it 'clusters' and can be detected by fluorescent image analysis. (Developed / commercialized by Norak, then Molecular Devices)] |
| vestibulocochlear nerve disease | DOID_12657 | |
| retrocochlear disease | DOID_2889 | |
| Kyasanur forest disease | DOID_11320 | [A viral infectious disease that is a hemorrhagic fever, has_material_basis_in Kyasanur forest disease virus, which is transmitted_by Haemaphysalis spinigera tick bite. The infection has_symptom fever, has_symptom headache, has_symptom stiffness of the neck, has_symptom severe muscle pain, has_symptom cough, has_symptom dehydration, and has_symptom bleeding problems.] |
| TruPoint assay kit | BAO_0001202 | |
| drug abuse assay | BAO_0002534 | |
| safety pharmacology assay | BAO_0002533 | |
| metastasis assay | BAO_0002535 | |
| Lactate kit | BAO_0001201 | |
| Transcreener assay kit | BAO_0001200 | |
| ileus | DOID_8440 |